Nanostructures for biomarker selection and identification by MS
| Organization: | ONE Nanotechnologies, LLC, CA, US |
| I.P. Brief: | Abiotic, artificial receptor technology is integrated into massively parallel nanostructured array devices for laser desorption ionization (LDI). This selectively amplifies and/or selectively attenuates individual biomarkers and other analytes in complex mixtures for facile high-throughput assay of human disease. |
| Keywords: | MALDI, SELDI, biomarker, cancer, nanotechnology, nanostructure, abiotic, fabrication |
| Primary Industry: | Biotech & Medical |
Full IP Descriptions available on-site.